Full Text View
Tabular View
No Study Results Posted
Related Studies
Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas
This study is currently recruiting participants.
Verified September 2012 by Novartis
Study NCT01433263   Information provided by Novartis

First Received on August 24, 2011.   Last Updated on September 28, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cachexia
Additional conditions recognized in this trial
Adenocarcinoma
Lung Neoplasms
More general conditions related to this trial
Body Weight
Body Weight Changes
Carcinoma
Emaciation
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Signs and Symptoms
Thoracic Neoplasms
Weight Loss
Interventions listed in this trial
BYM338 active drug
Placebo
Additional drug interventions recognized in this trial
Pancrelipase
More general drug interventions related to this trial
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Novartis Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services